Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”

Detalles Bibliográficos
Autores principales: Kim, Tark, Lee, Sang-Oh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167508/
https://www.ncbi.nlm.nih.gov/pubmed/30270586
http://dx.doi.org/10.3947/ic.2018.50.3.266
_version_ 1783360213995225088
author Kim, Tark
Lee, Sang-Oh
author_facet Kim, Tark
Lee, Sang-Oh
author_sort Kim, Tark
collection PubMed
description
format Online
Article
Text
id pubmed-6167508
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Korean Society of Infectious Diseases and Korean Society for Chemotherapy
record_format MEDLINE/PubMed
spelling pubmed-61675082018-10-04 Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia” Kim, Tark Lee, Sang-Oh Infect Chemother Correspondence The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2018-09 2018-09-20 /pmc/articles/PMC6167508/ /pubmed/30270586 http://dx.doi.org/10.3947/ic.2018.50.3.266 Text en Copyright © 2018 by The Korean Society of Infectious Diseases and Korean Society for Chemotherapy https://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Correspondence
Kim, Tark
Lee, Sang-Oh
Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
title Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
title_full Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
title_fullStr Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
title_full_unstemmed Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
title_short Reply: Correspondence Regarding the Article Titled “Low Lymphocyte Proportion in Bronchoalveolar Lavage Fluid as a Risk Factor Associated with the Change from Trimethoprim/sulfamethoxazole Used as First-Line Treatment for Pneumocystis jirovecii Pneumonia”
title_sort reply: correspondence regarding the article titled “low lymphocyte proportion in bronchoalveolar lavage fluid as a risk factor associated with the change from trimethoprim/sulfamethoxazole used as first-line treatment for pneumocystis jirovecii pneumonia”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167508/
https://www.ncbi.nlm.nih.gov/pubmed/30270586
http://dx.doi.org/10.3947/ic.2018.50.3.266
work_keys_str_mv AT kimtark replycorrespondenceregardingthearticletitledlowlymphocyteproportioninbronchoalveolarlavagefluidasariskfactorassociatedwiththechangefromtrimethoprimsulfamethoxazoleusedasfirstlinetreatmentforpneumocystisjiroveciipneumonia
AT leesangoh replycorrespondenceregardingthearticletitledlowlymphocyteproportioninbronchoalveolarlavagefluidasariskfactorassociatedwiththechangefromtrimethoprimsulfamethoxazoleusedasfirstlinetreatmentforpneumocystisjiroveciipneumonia

Ejemplares similares